David Turkaly
Stock Analyst at JMP Securities
(2.28)
# 1,441
Out of 4,412 analysts
88
Total ratings
41.07%
Success rate
-3.48%
Average return
Main Sectors:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OFIX Orthofix Medical | Reiterates: Market Perform | n/a | $12.99 | - | 1 | Apr 22, 2024 | |
| TELA TELA Bio | Reiterates: Market Outperform | $15 | $4.45 | +237.08% | 4 | Mar 22, 2024 | |
| KIDS OrthoPediatrics | Reiterates: Market Outperform | $50 | $30.26 | +65.23% | 6 | Mar 7, 2024 | |
| IART Integra LifeSciences Holdings | Maintains: Market Outperform | $55 → $49 | $28.34 | +72.90% | 10 | Feb 29, 2024 | |
| TFX Teleflex | Reiterates: Market Outperform | $285 | $206.71 | +37.87% | 10 | Feb 23, 2024 | |
| LNTH Lantheus Holdings | Reiterates: Market Outperform | $100 | $65.56 | +52.53% | 5 | Feb 23, 2024 | |
| STE STERIS | Reiterates: Market Outperform | $265 | $203.90 | +29.97% | 9 | Feb 8, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Outperform | $160 → $140 | $119.35 | +17.30% | 10 | Nov 13, 2023 | |
| NVRO Nevro | Maintains: Outperform | $75 → $40 | $11.32 | +253.36% | 5 | Aug 2, 2023 | |
| GMED Globus Medical | Reiterates: Market Perform | n/a | $50.55 | - | 1 | May 24, 2023 | |
| APYX Apyx Medical | Reiterates: Market Perform | n/a | $1.45 | - | 2 | May 24, 2023 | |
| HAE Haemonetics | Maintains: Market Outperform | $105 → $115 | $90.99 | +26.39% | 6 | May 12, 2023 | |
| STIM Neuronetics | Reiterates: Market Outperform | $12 | $3.49 | +243.84% | 4 | May 10, 2023 | |
| AXGN AxoGen | Reiterates: Market Outperform | $20 | $6.63 | +201.66% | 3 | May 10, 2023 | |
| FNA Paragon 28 | Reiterates: Market Outperform | $30 | $8.80 | +240.91% | 3 | May 5, 2023 | |
| SIBN SI-BONE | Reiterates: Market Outperform | $32 | $14.57 | +119.63% | 4 | May 2, 2023 | |
| ICAD iCAD, Inc. | Maintains: Outperform | $7 → $4 | $1.47 | +172.11% | 4 | Apr 13, 2023 | |
| CGNT Cognyte Software | Initiates: Outperform | n/a | $6.90 | - | 1 | Oct 6, 2017 |
Orthofix Medical
Apr 22, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $12.99
Upside: -
TELA Bio
Mar 22, 2024
Reiterates: Market Outperform
Price Target: $15
Current: $4.45
Upside: +237.08%
OrthoPediatrics
Mar 7, 2024
Reiterates: Market Outperform
Price Target: $50
Current: $30.26
Upside: +65.23%
Integra LifeSciences Holdings
Feb 29, 2024
Maintains: Market Outperform
Price Target: $55 → $49
Current: $28.34
Upside: +72.90%
Teleflex
Feb 23, 2024
Reiterates: Market Outperform
Price Target: $285
Current: $206.71
Upside: +37.87%
Lantheus Holdings
Feb 23, 2024
Reiterates: Market Outperform
Price Target: $100
Current: $65.56
Upside: +52.53%
STERIS
Feb 8, 2024
Reiterates: Market Outperform
Price Target: $265
Current: $203.90
Upside: +29.97%
Zimmer Biomet Holdings
Nov 13, 2023
Maintains: Market Outperform
Price Target: $160 → $140
Current: $119.35
Upside: +17.30%
Nevro
Aug 2, 2023
Maintains: Outperform
Price Target: $75 → $40
Current: $11.32
Upside: +253.36%
Globus Medical
May 24, 2023
Reiterates: Market Perform
Price Target: n/a
Current: $50.55
Upside: -
Apyx Medical
May 24, 2023
Reiterates: Market Perform
Price Target: n/a
Current: $1.45
Upside: -
Haemonetics
May 12, 2023
Maintains: Market Outperform
Price Target: $105 → $115
Current: $90.99
Upside: +26.39%
Neuronetics
May 10, 2023
Reiterates: Market Outperform
Price Target: $12
Current: $3.49
Upside: +243.84%
AxoGen
May 10, 2023
Reiterates: Market Outperform
Price Target: $20
Current: $6.63
Upside: +201.66%
Paragon 28
May 5, 2023
Reiterates: Market Outperform
Price Target: $30
Current: $8.80
Upside: +240.91%
SI-BONE
May 2, 2023
Reiterates: Market Outperform
Price Target: $32
Current: $14.57
Upside: +119.63%
iCAD, Inc.
Apr 13, 2023
Maintains: Outperform
Price Target: $7 → $4
Current: $1.47
Upside: +172.11%
Cognyte Software
Oct 6, 2017
Initiates: Outperform
Price Target: n/a
Current: $6.90
Upside: -